Anti-IL-6R 抗体 [EPR24322-143]
Anti-IL-6R antibody [EPR24322-143]
- BOND RX™ Validated
- 20ul selling size
- RabMAb
- Recombinant
- 詳細を見る
5
(1 Review)
|
(10 Publications)
Rabbit Recombinant Monoclonal IL-6R antibody. Suitable for ICC/IF, IP, WB, IHC-P and reacts with Human samples. Cited in 10 publications.
別名を表示する
CD126, Interleukin-6 receptor subunit alpha, IL-6 receptor subunit alpha, IL-6R subunit alpha, IL-6R-alpha, IL-6RA, IL-6R 1, Membrane glycoprotein 80, gp80, IL6R
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IL-6R antibody [EPR24322-143] (AB271042)
Immunohistochemical analysis of paraffin-embedded Human tonsil tissue labelling IL-6R with ab271042 at 1/2000 dilution (0.255 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Cyoplasmics staining on human tonsil. The section was incubated with ab271042 for 30 minutes at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 minutes.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IL-6R antibody [EPR24322-143] (AB271042)
Immunohistochemical analysis of paraffin-embedded Human placenta tissue labelling IL-6R with ab271042 at 1/2000 dilution (0.255 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Cyoplasmics staining on human placenta (PMID : 25658637). The section was incubated with ab271042 for 30 minutes at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 minutes.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-IL-6R antibody [EPR24322-143] (AB271042)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized U266B1 cells labelling IL-6R with ab271042 at 1/50 dilution, followed by ab150077 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) antibody at 1/1000 dilution (Green). Confocal image showing cytoplasmic staining in U266B1 cells. Negative control : K-562 (PMID : 8300137) is observed. ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 dilution (Red). The Nuclear counterstain was DAPI (Blue).
Secondary antibody only control : Secondary antibody is ab150077 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) at 1/1000 dilution.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IL-6R antibody [EPR24322-143] (AB271042)
Immunohistochemical analysis of paraffin-embedded Human thyroid carcinoma tissue labelling IL-6R with ab271042 at 1/2000 dilution (0.255 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Cyoplasmics staining on human thyroid carcinoma. The section was incubated with ab271042 for 30 minutes at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 minutes.
- IP
Supplier Data
Immunoprecipitation - Anti-IL-6R antibody [EPR24322-143] (AB271042)
IL-6R was immunoprecipitated from 0.35 mg U266B1 (human multiple myeloma B lymphocyte) whole cell lysate 10 ug with ab271042 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab271042 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : U266B1 (human multiple myeloma B lymphocyte) whole cell lysate 10 ug
Lane 2 : ab271042 IP in U266B1 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab271042 in U266B1 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 5.5 seconds
All lanes:
Immunoprecipitation - Anti-IL-6R antibody [EPR24322-143] (ab271042)
Predicted band size: 52 kDa
Observed band size: 70-80 kDa
false
- WB
Lab
Western blot - Anti-IL-6R antibody [EPR24322-143] (AB271042)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
The observed MW is consistent with what has been described in the literature (PMID : 28276471, 21282511).
Negative control : K-562 (PMID : 8300137)
This blot was developed using a higher sensitivity ECL substrate.
Exposure time : 37 seconds
All lanes:
Western blot - Anti-IL-6R antibody [EPR24322-143] (ab271042) at 1/1000 dilution
Lane 1:
U266B1 (human multiple myeloma B lymphocyte) whole cell lysate at 20 µg
Lane 2:
K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 52 kDa
Observed band size: 70-80 kDa
false
関連する標識済み抗体及び組成の異なる製品 (8)
-
Anti-IL-6R antibody [EPR24322-143] - BSA and Azide free
-
660 APC
APC Anti-IL-6R antibody [EPR24322-143]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-IL-6R antibody [EPR24322-143]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-IL-6R antibody [EPR24322-143]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-IL-6R antibody [EPR24322-143]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-IL-6R antibody [EPR24322-143]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-IL-6R antibody [EPR24322-143]
-
578 PE
PE Anti-IL-6R antibody [EPR24322-143]
Reactivity data
製品の詳細
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IL-6 receptor function involves mediating the effects of IL-6 through its interaction with glycoprotein 130 (gp130) forming a signaling complex. This complex initiates intracellular pathways that lead to gene expression changes necessary for immune responses inflammation and hematopoiesis. When IL-6 binds IL-6R the complex formation with gp130 triggers downstream signaling that impacts cell growth differentiation and survival.
Pathways
IL-6R is central to the JAK/STAT signaling pathway one of the two main pathways activated by IL-6 signaling. It's also involved in the MAPK cascade contributing to cellular responses such as proliferation and differentiation. Through these pathways IL-6R interacts with other proteins like JAK kinases and STAT transcription factors coordinating cellular responses to external signals.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (10)
Recent publications for all applications. Explore the full list and refine your search
Antioxidants (Basel, Switzerland) 14: PubMed40867839
2025
Applications
Unspecified application
Species
Unspecified reactive species
BJC reports 3:49 PubMed40624140
2025
Applications
Unspecified application
Species
Unspecified reactive species
Respiratory research 26:180 PubMed40349069
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 15:1483896 PubMed39845783
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of immunopathology and pharmacology 38:3946320241297342 PubMed39475763
2024
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 10:e37715 PubMed39315204
2024
Applications
Unspecified application
Species
Unspecified reactive species
Emerging microbes & infections 13:2366359 PubMed38855910
2024
Applications
Unspecified application
Species
Unspecified reactive species
Neoplasia (New York, N.Y.) 48:100960 PubMed38184887
2024
Applications
Unspecified application
Species
Unspecified reactive species
Aging 15:8113-8136 PubMed37595258
2023
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of the United States of America 119: PubMed35027451
2022
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com